COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.


Journal

Cerebrovascular diseases (Basel, Switzerland)
ISSN: 1421-9786
Titre abrégé: Cerebrovasc Dis
Pays: Switzerland
ID NLM: 9100851

Informations de publication

Date de publication:
2021
Historique:
received: 24 11 2020
accepted: 21 04 2021
pubmed: 28 6 2021
medline: 21 12 2021
entrez: 27 6 2021
Statut: ppublish

Résumé

To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LAC in 2020 compared to 2019 (1,786 vs. 2,159, respectively, χ2 goodness of fit test p < 0.0001) across 9 participating comprehensive stroke centers. Patients who did not receive any reperfusion therapy decreased by 16.6% in 2020 (1,527) compared to 2019 (1,832). Patients who received only intravenous thrombolytic (IVT) therapy decreased by 31.8% (107 vs. 157). Patients who received only mechanical thrombectomy (MT) increased by 3% (102 vs. 99). Patients who received both IVT and MT decreased by 31.8% (45 vs. 66). Recanalization treatment times in 2020 were comparable to 2019. CSCs serving a higher proportion of Latinx populations in the eastern parts of LAC experienced a higher incidence of MT in 2020 compared to 2019. Mild increase in stroke severity was seen in 2020 compared to 2019 (8.95 vs. 8.23, p = 0.046). A higher percentage of patients were discharged home in 2020 compared to 2019 (59.5 vs. 56.1%, p = 0.034), a lower percentage of patients were discharged to skilled nursing facility (16.1 vs. 20.7%, p = 0.0004), and a higher percentage of patients expired (8.6 vs. 6.3%, p = 0.008). LAC saw a decrease in overall stroke code activations in 2020 compared to 2019. Reperfusion treatment times remained comparable to prepandemic metrics. There has been an increase in severe stroke incidence and higher volume of thrombectomy treatments in Latinx communities within LAC during the pandemic of 2020. More patients were discharged home, less patients discharged to skilled nursing facilities, and more patients expired in 2020, compared to the same time frame in 2019.

Identifiants

pubmed: 34175851
pii: 000516908
doi: 10.1159/000516908
pmc: PMC8339042
doi:

Substances chimiques

Fibrinolytic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

707-714

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

M Maximillian Padrick (MM)

Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA, maxpadrick@gmail.com.

Navdeep Sangha (N)

Kaiser Permanente, Los Angeles Medical Center, Los Angeles, California, USA.

Laurie Paletz (L)

Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA.

James Mirocha (J)

Cedars-Sinai Medical Center, Biostatistics and Bioinformatics Research Center, Los Angeles, California, USA.

Sonia Figueroa (S)

Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Vicki Manoukian (V)

Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Konrad Schlick (K)

Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Patrick D Lyden (PD)

Zilka Neurogenetic Institute at Keck School of Medicine of USC, Los Angeles, California, USA.

David S Liebeskind (DS)

Department of Neurology, University of California, Los Angeles, California, USA.

Fiona K Chatfield (FK)

Department of Neurology, University of California, Los Angeles, California, USA.

Jason W Tarpley (JW)

Providence Saint John's Health Center, Santa Monica, California, USA.
Providence Little Company of Mary Medical Center- Torrance, Torrance, California, USA.

Adrian Burgos (A)

PIH Health Whittier Hospital, Whittier, California, USA.

Matthew Tenser (M)

Department of Neurosurgery, University of Southern California, Los Angeles, California, USA.
PIH Health Good Samaritan Hospital, Los Angeles, California, USA.

Denise Gaffney (D)

Kaiser Permanente, Los Angeles Medical Center, Los Angeles, California, USA.

Marco A Pech (MA)

Torrance Memorial Medical Center, Torrance, California, USA.

Edward Nazareth (E)

Torrance Memorial Medical Center, Torrance, California, USA.

Robert Jackson (R)

Providence Saint John's Health Center, Santa Monica, California, USA.

Helaine Kauffman (H)

Providence Saint John's Health Center, Santa Monica, California, USA.
Providence Little Company of Mary Medical Center- Torrance, Torrance, California, USA.
Torrance Memorial Medical Center, Torrance, California, USA.

Lisa Arnold (L)

Providence Saint John's Health Center, Santa Monica, California, USA.

Jennifer Cox (J)

Providence Saint Joseph Medical Center, Burbank, California, USA.

Treasure Joyce (T)

Providence Little Company of Mary Medical Center- Torrance, Torrance, California, USA.

Catrice Nakamura (C)

Providence Little Company of Mary Medical Center- Torrance, Torrance, California, USA.

Darcie Fitzgerald (D)

Providence Little Company of Mary Medical Center- Torrance, Torrance, California, USA.

Kyle Ogami (K)

Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Nili Steiner (N)

Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Nicole Wolber (N)

Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Betty Robertson (B)

Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Rachel Izzo (R)

Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Stefanie Gorski (S)

PIH Health Whittier Hospital, Whittier, California, USA.

Heather Manuel (H)

PIH Health Whittier Hospital, Whittier, California, USA.

Krystal Valdez (K)

Providence Little Company of Mary Medical Center- Torrance, Torrance, California, USA.
Department of Neurosurgery, University of Southern California, Los Angeles, California, USA.

Liliana Reyes (L)

Department of Neurosurgery, University of Southern California, Los Angeles, California, USA.

Latisha K Sharma (LK)

Zilka Neurogenetic Institute at Keck School of Medicine of USC, Los Angeles, California, USA.

Shlee S Song (SS)

Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH